| Identification | Back Directory | [Name]
15-Tetracosenamide, N-[(1S,2R,3E,7Z)-2-hydroxy-1-(hydroxymethyl)-3,7-heptadecadien-1-yl]-, (15Z)- | [CAS]
2260670-17-3 | [Synonyms]
15-Tetracosenamide, N-[(1S,2R,3E,7Z)-2-hydroxy-1-(hydroxymethyl)-3,7-heptadecadien-1-yl]-, (15Z)- | [Molecular Formula]
C42H79NO3 | [MOL File]
2260670-17-3.mol | [Molecular Weight]
646.08 |
| Chemical Properties | Back Directory | [Boiling point ]
749.3±60.0 °C(Predicted) | [density ]
0.917±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C | [form ]
powder | [pka]
13.50±0.20(Predicted) |
| Hazard Information | Back Directory | [Biological Activity]
C24:1 Ceramide in a stable isotope form is suitable for a newly described validated liquid chromatography-tandem mass spectrometry methodology for their clinical-scaled measurement. |
|
|